Physician profile
Katie Ann Gresham
NPI 1003589631
$10,452.35
in general payments reported to CMS, 2019-2025
45 companies · $2,428 in 2025
The $2,428 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $370 · 2022: $3,386 · 2023: $2,289 · 2024: $1,979 · 2025: $2,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,696.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $1,681.56 | 2022-2023 | Afrezza |
| Lilly USA, LLC | $1,028.37 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $735.65 | 2021-2025 | |
| Novo Nordisk INC | $700.36 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $565.40 | 2021-2025 | Korlym |
| Amgen INC. | $528.04 | 2023-2025 | Tepezza, Evenity, Prolia |
| Dexcom, INC. | $489.63 | 2021-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $449.43 | 2022-2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $430.83 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Sanofi-Aventis U.S. LLC | $416.34 | 2023-2025 | |
| Medtronic, INC. | $408.48 | 2022-2025 | Minimed 780g |
| Antares Pharma, INC. | $382.04 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Tandem Diabetes Care, INC. | $337.15 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ibsa Pharma INC. | $323.51 | 2022-2025 | Tirosint, Tirosint, Licart |
| Abbvie INC. | $240.27 | 2022-2023 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Gresham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.